A detailed history of Inspire Investing, LLC transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Inspire Investing, LLC holds 20,361 shares of ROIV stock, worth $348,376. This represents 0.03% of its overall portfolio holdings.

Number of Shares
20,361
Previous 24,896 18.22%
Holding current value
$348,376
Previous $280,000 10.0%
% of portfolio
0.03%
Previous 0.03%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 15, 2025

SELL
$10.74 - $15.28 $48,705 - $69,294
-4,535 Reduced 18.22%
20,361 $308,000
Q2 2025

Jul 24, 2025

SELL
$9.08 - $11.62 $46,180 - $59,099
-5,086 Reduced 16.96%
24,896 $280,000
Q1 2025

Jun 03, 2025

BUY
$10.09 - $12.08 $302,518 - $362,182
29,982 New
29,982 $302,000

Others Institutions Holding ROIV

About Roivant Sciences Ltd.


  • Ticker ROIV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 704,382,976
  • Market Cap $12.1B
  • Description
  • Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...
More about ROIV
Track This Portfolio

Track Inspire Investing, LLC Portfolio

Follow Inspire Investing, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Inspire Investing, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Inspire Investing, LLC with notifications on news.